BSE filing, NSE: MARKSANS. Summary written from the filing by ALFA Finder's alert engine.
Marksans Pharma Ltd: key numbers
- Share price
- ₹301.00
- Market cap
- ₹13,640 Cr
- Revenue (annual)
- ₹2,951 Cr
- Net profit (annual)
- ₹417.9 Cr
- P/E (TTM)
- 24.4×Sector 41.3×
- Promoter holding
- 43.87%+0.00% QoQ
- FII holding
- 19.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Marksans Pharma Ltd
All →Marksans Pharma Results Update
Marksans Pharma reported Q2FY27 revenue of ₹940 crore and H1FY27 PAT of ₹303 crore. EBITDA grew 48% to a record ₹214 crore in the quarter.
Marksans Pharma Investor Presentation: Key Takeaways
Q2FY27 revenue ₹940cr (+30.5% YoY), EBITDA ₹214cr at 22.8% margin (+274bps), PAT ₹143.5cr (+44.8%). H1 PAT ₹303cr; net cash ₹1,095cr; Europe front-end being built.
Marksans Pharma Q2 FY27 Results: Net Profit ₹143.5 Cr, Up 44.8% YoY
Marksans Pharma Ltd reported revenue from operations of ₹940.2 Cr (+30.5% YoY) and net profit of ₹143.5 Cr (+44.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹143.5 Cr · +44.8% YoY
Marksans Pharma Board Meeting Date
Marksans Pharma scheduled its Board meeting for November 4, 2026, to approve Q1/H1 unaudited results. No material decision has been taken yet.
Marksans Pharma Other Announcement
Periodic quarterly shareholding pattern filing for Marksans Pharma Ltd. This document provides the latest breakdown of shareholder categories as mandated by SEBI.
Marksans Pharma Promoter Selling (Off-Market)
Director Sandra Saldanha gifted 2,28,273 shares of Marksans Pharma Ltd to her daughters in an off-market transaction. This internal transfer reallocates promoter-group equity holdings.
Other employee stock options announcements
All →Tamilnad Mercantile Bank Employee Stock Options
Tamilnad Mercantile Bank allotted 2,364 equity shares to employees exercising options under its ESOP 2024. Paid-up capital rises to 15,83,53,818 shares.
Vedanta Iron and Steel Employee Stock Options
Vedanta Iron And Steel disclosed the vesting of 2023 ESOS grants on 4 November 2026, covering 55,16,340 options across the demerged group. No exercise price or money realised is determined yet.
- Execution
- 8 months from vesting, or such other period as approved by the NRC
Affle 3I Employee Stock Options
Affle 3i disclosed PIT trades on 2-4 November 2026 covering ESOP-related transfers and designated-person purchases. Rows total about Rs.0.42 Crore in value.
Lodha Developers Employee Stock Options
Lodha Developers allotted 56,654 equity shares under its ESOP 2021-II scheme on November 4, 2026. No price or consideration amount is disclosed.
Cian Healthcare Employee Stock Options
Cian Healthcare granted 2,00,000 employee stock options at Rs 15 each on 4 November 2026. Options vest after one year, exercisable for five years thereafter.
Kirloskar Oil Engines Employee Stock Options
Kirloskar Oil Engines allotted 3,859 equity shares to employees on exercise of ESOPs under its 2019 plan. It also appointed Amruta Thigale as Company Secretary and KMP.